03/12/2025
4:30 PM | Lineage Cell Therapeutics (Issuer)
Samuel George A. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
4:30 PM | Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
4:30 PM | Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
3:15 PM | Lineage Cell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/28/2025
7:07 PM | BROADWOOD PARTNERS, L.P. (Filed by)
Lineage Cell Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
01/28/2025
6:49 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:30 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
3:30 PM | Lineage Cell Therapeutics (Filer)
| Form DEF 14A | |
11/29/2024
3:30 PM | Lineage Cell Therapeutics (Filer)
| Form PRE 14A | |
11/26/2024
3:55 PM | Lineage Cell Therapeutics (Issuer)
Samuel George A. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:58 PM | Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LCTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/22/2024
8:00 AM | Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
7:05 PM | BROADWOOD PARTNERS, L.P. (Filed by)
Lineage Cell Therapeutics (Subject)
| Form SC 13D/A | |
11/21/2024
7:55 AM | Lineage Cell Therapeutics (Filer)
| Form 424B5 | |
11/20/2024
4:08 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Lineage Cell Therapeutics (Subject)
| Form SC 13G | |
08/19/2024
5:24 PM | Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:00 PM | BRADSHER NEAL C (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:30 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
8:11 AM | Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
11:15 PM | Lineage Cell Therapeutics (Filer)
| Form EFFECT | |
05/14/2024
3:39 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:10 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:50 PM | Lineage Cell Therapeutics (Filer)
| Form ARS | |
04/29/2024
3:40 PM | Lineage Cell Therapeutics (Filer)
| Form DEFA14A | |
